Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 8, 1999, Pages 1469-1481

  Jones, Keith ^a,b   Flaherty, Michael P ^a   Tang, Xian Liang ^a   Takano, Hitoshi ^a   Qiu, Yumin ^a   Banerjee, Supratim ^a   Smith, Traci ^a   Bolli, Roberto ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

iNOS; Ischemia; Rabbit

Indexed keywords

COMPLEMENTARY DNA; GLYCERYL TRINITRATE; MESSENGER RNA; N(G) NITROARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME INDUCTION; HEART INFARCTION PREVENTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033179252     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0983     Document Type: Article

References (64)

1. Bachmaier K.N., Neu C., Pummerer G.S., Duncan T.W., Mak T., Matsuyama T., Penninger J.M. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation. 96:1997;585-591.
2. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., Pimental D., Malinski T.A., Kapturczak M., Taha Z., Lowenstein C.J., Davidoff A.J., Kelly R.A. CytoÍkine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 269:1994;27580-27588.
3. Balligand J.L., Cannon P.J. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol. 17:1997;1846-1858.
4. Bandaletova T.I., Brouet H., Bartsch T., Sugimura H., Esumi H., Ohshima H. Immunohistochemical localization of an inducible form of nitric oxide synthase in various organs of rats treated with Propionibacterium acnes and lipopolysaccharide. APMIS. 101:1993;330-336.
5. Banerjee S., Tang X-L, Qiu Y., Takano H., Manchikalapudi S., Dawn B., Shirk G., Bolli R. Nitroglycerin induces late preconditioning against myocardial stunning via a protein kinase C mediated pathway in conscious rabbits. (Abstract). Circulation. 98:1998;I-417.
6. Bing R.J., Suzuki H. Myocardial infarction and nitric oxide. Mol Cell Biochem. 161:1996;303-306.
7. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol. 91:1996;57-63.
8. Bolli R., Bhatti Z.A., Tang X.L., Qiu Y., Zhang Q., Guo Y., Jadoon A.K. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 81:1997a;42-52.
9. Bolli R., Manchikalapudi S., Tang X-L, Takano H., Qiu Y., Zhang Q., Jadoon A.K. The protective effects of late PC against myocardial stunning in conscious rabbits are mediated by nitric oxide synthase: evidence that nitric oxide acts as both a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res. 81:1997b;1094-1107.
10. Bolli R., Dawn B., Tang X-L, Qiu Y., Ping P., Xuan Y-T, Jones W.K., Takano H., Guo Y., Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol. 93:1998;325-338.
11. Buchwalow I.B., Schulze W., Kostic M.M., Wallukat G., Morwinski R. Intracellular localization of inducible nitric oxide synthase in neonatal rat cardiomyocytes in culture. Acta Histochem. 99:1997;231-240.
12. Buttery L.D., Evans T.J., Springall D.R., Carpenter A., Cohen J., Polak J.M. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest. 71:1994;755-764.
13. Chandrasekar B., Freeman G.L. Induction of nuclear factor kappa B and activation protein 1 in postischemic myocardium. FEBS Lett. 401:1997;30-34.
14. Chandrasekar B., Streitman J.E., Colston J.T., Freeman G.L. Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. BioÍchim Biophys Acta. 1406:1998;91-106.
15. Dawn B., Qiu Y., Tang X-L, Takano H., Banerjee S., Bolli R. Involvement of tyrosine kinases in the development of late preconditioning against myocardial stunning in conscious rabbits. (Abstract). J Mol Cell Cardiol. 30:1998a;A264.
16. Dawn B., Qiu Y., Tang X-L, Takano H., Banerjee S., Bolli R. The protective effects of late preconditioning are mediated by tyrosine kinase activity in conscious rabbits. (Abstract). Circulation. 98:1998b;I-586.
17. Dudek R.R., Wildhirt S., Pinto V., Giesler G., Bing R.J. Dexamethasone inhibits the expression of an inducible nitric oxide synthase in infarcted rabbit myocardium. Biochem Biophys Res Commun. 202:1994a;1120-1126.
18. Dudek R.R., Wildhirt S., Conforto A., Pinto V., Suzuki H., Winder S., Bing R.J. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit. Biochem Biophys Res Commun. 205:1994b;1671-1680.
19. Elliott G.T. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J Mol Cell Cardiol. 30:1998;3-17.
20. Forstermann U., Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol. 352:1995;351-364.
21. Guo Y., Bao W., Tang X-L, Wu W-J, Bolli R. Nitric oxide donors induce late preconditioning against myocardial infarction in mice. J Mol Cell Cardiol. 1998.
22. Gurevitch J., Frolkis I., Yuhas Y., Paz Y., Matsa M., Mohr R., Yakirevich V. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol. 28:1996;247-252.
23. Hierholzer C., Harbrecht B., Menezes J.M., Kane J., Macmicking J., Nathan C.F., Peitzman A.B., Billiar T.R., Tweardy D.J. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med. 187:1998;917-928.
24. Jones W.K., Grupp I., Doetschman T., Grupp G., Osinska H., Hewett T., Boivin G., Gulick J., Ng W., Robbins J. Ablation of the cardiac MyHC chain gene leads to gene dosage effects and functional deficits in the heart. J Clin Invest. 98:1996;1906-1917.
25. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitno J., Shapiro D., Le J., Koh I., Kimura T., Green S.J., Mak T., Taniguchi T., Vilcek J. Requirement for transduction factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
26. Kinugawa K., Shimizu T., Yao A., Kohmoto O., Serizawa T., Takahashi T. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res. 81:1997;911-921.
27. Kone B.C., Schwobel J., Turner P., Mohaupt M.G., Cangro C.B. Role of NF-kappa B in the regulation of inducible nitric oxide synthase in an MTAL cell line. Am J Physiol. 269:1995;F718-F729.
28. Kuzuya T., Hoshida S., Yamashita N., Fuji H., Oe H., Hori M., Kamada T., Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 72:1993;1293-1299.
29. Lander H.M., Sehajpal P.K., Novogrodsky A. Nitric oxide signaling: a possible role for G proteins. J Immunol. 151:1993;7182-7187.
30. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J Biol Chem. 270:1995;7017-7020.
31. LaPointe M.C., Sitkins J.R. Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes. Hypertension. 27:1996;709-714.
32. Liu P., Hock C.E., Nagele R., Wong P.Y. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol. 272:1997;H2327-H2336.
33. Maldonado C., Qiu Y., Tang X-L, Cohen M.V., Auchampach J., Bolli R. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol. 273:1997;H1324-H1332.
34. Marber M.S., Yellon D.M. Myocardial adaptation, stress proteins, and the second window of protection. Ann NY Acad Sci. 793:1996;123-141.
35. McKenna T.M., Li S., Tao S. PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol. 269:1995;H1891-H1898.
36. Moroz L.L., Norby S.W., Cruz L., Sweedler J.V., Gillette R., Clarkson R.B. Non-enzymatic produciton of nitric oxide (NO) from NO synthase inhibitors. Biochem Biophys Res Commun. 253:1998;571-576.
37. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia; a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
38. Nagasaki A., Gotoh T., Takeya M., Yu Y., Takiguchi M., Matsuzaki H., Takatsuki K., Mori M. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immunohistochemical analyses. J Biol Chem. 271:1996;2658-2662.
39. Node K., Kitakaze M., Kosaka H., Komamura K., Minamino T., Tada M., Inoue M., Hori M., Kamada T. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun. 211:1995;370-374.
40. Pan J., Burgher K.L., Szczepanik A.M., Ringheim G.E. Tyrosine phosphorylation of inducible nitric oxide synthase: implications for potential post-translational regulation. Biochem J. 314:1996;889-894.
41. Peng M., Huang L., Xie Z.J., Huang W.H., Askari A. Oxidant-induced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes. Cell Mol Biol Res. 41:1995;189-197.
42. Ping P., Li R.C.X., Zhang J., Tang X-L, Qiu Y., Banerjee S., Zheng Y-T, Bolli R. Ischemic preconditioning (PC) induces selective activation of Src and Lck tyrosine kinases in conscious rabbits via a PKC-dependent pathway. (Abstract). Circulation. 98:1998a;I-71.
43. Ping P., Zhang J., Cao X., Kong D., Tang X-L, Qiu Y., Manchikalapudi S., Li RC-X, Bolli R. PKC-dependent activation of P44/P42 during myocardial ischemia/reperfusion in conscious rabbits. Am J Physiol. In press.
44. Ping P., Zhang J., Qiu Y., Tang X-L, Manchikalapudi S., Cao X., Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits. Circ Res. 81:1997;404-413.
45. Qiu Y., R A., Tang X-L, Manchikalpudi S., Takano H., Jadoon A.K., Wu W-J, Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 273:1997;H2931-H2936.
46. Robbins J., Gulick J., Sánchez A., Howles P., Doetschman T. Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J Biol Chem. 265:1990;11905-11909.
47. Seki T., Hagiwara H., Naruse K., Kadowaki M., Kashiwagi M., Demura H., Hirose S., Naruse M. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes. Biochem Biophys Res Commun. 218:1996;601-605.
48. Shindo T., Ikeda U., Ohkawa F., Kawahara Y., Yokoyama M., Shimada K. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res. 29:1995;813-819.
49. Schulz R., Nava E., Moncada S. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 105:1992;575-580.
50. Subramanium A., Jones W.K., Gulick J., Wert S., Neumann J., Robbins J. Tissue-specific regulation of the α -myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 266:1991;24613-24620.
51. Sun J-Z, Tang X-L, Knowlton A.A., Park S.W., Qiu Y., Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 95:1995;388-403.
52. Suzuki H., Wildhirt S.M., Dudek R.R., Narayan K.S., Bailey A.H., Bing R.J. Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages. Tissue Cell. 28:1996;89-97.
53. Takano H., Manchikalapudi S., Tang X-L, Qiu Y., Rizvi A., Jadoon A.K., Zhang Q., Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 98:1998a;441-449.
54. Takano H., Tang X-L, Qiu Y., Guo Y., French B., Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant sensitive mechanism. Circ Res. 83:1998b;73-84.
55. Tosaki A., Maulik N., Elliott G.T., Blasig I.E., Engelman R.M., Das D.K. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J Pharmacol Exp Ther. 285:1998;1274-1279.
56. Wallenstein S., Zucker C.L., Fleiss J.L. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.
57. Wang Y., Marsden P.A. Nitric oxide synthases: gene structure and regulation. Adv Pharmacol. 34:1995;71-90.
58. Wang P., Zweir J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. 271:1996;29223-29230.
59. Wildhirt S.M., Dudek R.R., Suzuki H., Bing R.J. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction. Int J Cardiol. 50:1995a;253-261.
60. Wildhirt S.M., Dudek R.R., Suzuki H., Pinto V., Narayan K.S., Bing R.J. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res. 29:1995b;526-531.
61. Xuan Y-T, Tang X-L, Qiu Y., Banerjee S., Takano H., Han H., Bolli R. Direct evidence that NOS is the mediator of late preconditioning in conscious rabbits. (Abstract). Circulation. 98:1998;I-417.
62. Xuan Y-T, Tang X-L, Qiu Y., Banerjee S., Takano H., Han H., Bolli R. Nuclear factor kappa B plays an essential role in the late phase of ischemic preconditioning in the conscious rabbit. Circ Res. 31:1999;1095-1109.
63. Yang X.M., Baxter G.F., Heads R.J., Yellon D.M., Downey J.M., Cohen M.V. Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res. 31:1996;777-783.
64. Zhao L., Weber P.A., Smith J.R., Comerford M.L., Elliott G.T. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monoÍphosphoryl lipid A. J Mol Cell Cardiol. 29:1997;1567-1576.